Gossamer Bio, Inc. (GOSS) Financials
GOSS Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 311.9 million | 249.1 million |
2023-09-30 | 347.9 million | 243.3 million |
2023-06-30 | 181.7 million | 244.5 million |
2023-03-31 | 219.9 million | 248.4 million |
GOSS Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -33.4 million | 6.0 million |
2023-09-30 | -34.5 million | 6.2 million |
2023-06-30 | -38.3 million | 8.2 million |
2023-03-31 | -53.0 million | 8.1 million |
GOSS Net Income
No data available :(
GOSS Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 296.4 million | - | 3.4 million |
2023-09-30 | 328.9 million | - | 4.2 million |
2023-06-30 | 162.1 million | - | 5.0 million |
2023-03-31 | 201.9 million | - | 5.7 million |
GOSS Shares Outstanding
GOSS Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | - | 29.7 million | 9.1 million | 714000 |
2023-09-30 | 30000 | 31.2 million | 9.3 million | - |
2023-06-30 | 15000 | 36.3 million | 10.0 million | - |
2023-03-31 | 15000 | 37.8 million | 10.1 million | - |
GOSS Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | - | 1.0 million |
2023-09-30 | - | 1.1 million |
2023-06-30 | - | 1.2 million |
2023-03-31 | - | 1.1 million |
GOSS
Price: $0.67
52 week price:
Earnings Per Share: -1.18 USD
P/E Ratio: -0.54
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 916653
Market Capitalization: 203.2 million